These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1149007)

  • 21. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo.
    Siddik ZH; Thai G; Yoshida M; Zhang YP; Khokhar AR
    Anticancer Drug Des; 1994 Dec; 9(6):495-509. PubMed ID: 7880375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of treatment schedule on antitumor activity of glycolate-0,0'-diammineplatinum(II), a new platinum derivative: comparison with cis-diamminedichloroplatinum(II).
    Suzumura Y; Kato T; Ueda R; Ota K
    Anticancer Res; 1989; 9(4):1083-8. PubMed ID: 2817790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.
    Schabel FM; Trader MW; Laster WR; Corbett TH; Griswold DP
    Cancer Treat Rep; 1979; 63(9-10):1459-73. PubMed ID: 291480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor activity of 1,2-diaminocyclohexane--platinum complexes against sarcoma-180 ascites form.
    Kidani Y; Inagaki K; Iigo M; Hoshi A; Kuretani K
    J Med Chem; 1978 Dec; 21(12):1315-8. PubMed ID: 722741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some substituted naphthazarins as potential anticancer agents.
    Paull KD; Zee-Cheng RK; Cheng CC
    J Med Chem; 1976 Feb; 19(2):337-9. PubMed ID: 1061817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atopic hypersensitivity to cis-dichlorodiammineplatinum(II) and other platinum complexes.
    Khan A; Hill JM; Grater W; Loeb E; MacLellan A; Hill N
    Cancer Res; 1975 Oct; 35(10):2766-70. PubMed ID: 50881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antileukemic properties of organoplatinum complexes.
    Meischen SJ; Gale GR; Lake LM; Frangakis CJ; Rosenblum MG; Walker EM; Atkins LM; Smith AB
    J Natl Cancer Inst; 1976 Oct; 57(4):841-5. PubMed ID: 1003531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An approach to tumour biology in the light of prevention, cure and etiology.
    Bose S; Chowdhury JR
    Indian J Cancer; 1972 Jun; 9(2):138-41. PubMed ID: 4635904
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug resistance induction and cross-resistance studies with Pt-complexes.
    Hrubisko M; Balázová E; Ujházy V
    Neoplasma; 1984; 31(6):649-53. PubMed ID: 6542968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor action of two rhodium and ruthenium complexes in comparison with cis-diamminedichloroplatinum(II).
    Giraldi T; Sava G; Bertoli G; Mestroni G; Zassinovich G
    Cancer Res; 1977 Aug; 37(8 Pt 1):2662-6. PubMed ID: 872094
    [No Abstract]   [Full Text] [Related]  

  • 31. Cytostatic and antitumour properties of a new series of Pt (II) complexes with cyclopentylamine.
    Craciunescu DG; Scarcia V; Furlani A; Doadrio A; Ghirvu C; Ravalico L
    In Vivo; 1987; 1(4):229-34. PubMed ID: 2979788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor activity of a new platinum complex, 2-aminomethyl-pyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II).
    Endoh K; Akamatsu K; Matsumoto T; Morikawa K; Honda M; Mitsui H; Koizumi M; Koizumi K; Matsuno T
    Anticancer Res; 1989; 9(4):987-91. PubMed ID: 2817826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
    Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
    Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, characterization, and properties of a group of platinum (IV) complexes.
    Brandon RJ; Dabrowiak JC
    J Med Chem; 1984 Jul; 27(7):861-5. PubMed ID: 6330359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor activity of cis-dichlorodiammineplatinum(II).
    Wolpert-DeFilippes MK
    Cancer Treat Rep; 1979; 63(9-10):1453-8. PubMed ID: 498146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor activity of N-heterocyclic carboxaldehyde thiosemicarbazone derivatives.
    Iigo M; Hoshi A; Kuretani K; Natsume M
    Gan; 1977 Apr; 68(2):221-5. PubMed ID: 892296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antitumor activity of the components of a carminomycin complex].
    Shorin VA; Bazhanov VS; Averbukh LA
    Antibiotiki; 1977 Jan; 22(1):69-74. PubMed ID: 576573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The successful regression of large solid sarcoma 180 tumors by platinum compounds.
    Rosenberg B; VanCamp L
    Cancer Res; 1970 Jun; 30(6):1799-802. PubMed ID: 5457941
    [No Abstract]   [Full Text] [Related]  

  • 39. Methods of screening anticancer drugs in the soviet union.
    Larionov LF
    Cancer Chemother Rep; 1970 Apr; 54(2):71-7. PubMed ID: 5527014
    [No Abstract]   [Full Text] [Related]  

  • 40. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
    Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
    J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.